EOLS's three largest insider shareholders as of April 22, 2026 are Inc. Medytox (Other, 3.38Mn shares), Vikram Malik (Director, 1.14Mn shares), David Moatazedi (Director, 604.70K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Inc. Medytox | - | 3,381,326 | 0 | 18 Oct, 2023 |
| Vikram Malik | - | 0 | 1,143,701 | 25 Aug, 2021 |
| David Moatazedi | - | 604,700 | 0 | 20 Mar, 2026 |
| Simone Blank | - | 0 | 482,783 | 15 Aug, 2023 |
| Rui Avelar | - | 427,423 | 0 | 20 Mar, 2026 |
| Vikram Malik | - | 321,109 | 0 | 19 Feb, 2026 |
| Tatjana Mitchell | Chief Financial Officer | 226,092 | 0 | 19 Feb, 2026 |
| Sandra Beaver | Chief Financial Officer | 167,089 | 0 | 14 May, 2025 |
| Lauren P Silvernail | - | 141,571 | 0 | 18 May, 2022 |
| Crystal Muilenburg | Chief Marketing Officer | 134,248 | 0 | 10 Mar, 2022 |
| Brady Stewart | - | 134,188 | 0 | 19 Feb, 2026 |
| Albert G Iii White | - | 95,937 | 0 | 19 Feb, 2026 |
| Tomoko Yamagishi-Dressler | Chief Marketing Officer | 89,949 | 0 | 26 Aug, 2025 |
| David N Gill | - | 86,887 | 0 | 19 Feb, 2026 |
| Karah Herdman Parschauer | - | 77,742 | 0 | 19 Feb, 2026 |
| Simone Blank | - | 77,111 | 0 | 11 Mar, 2025 |
| Robert Hayman | - | 54,856 | 0 | 09 Feb, 2024 |
| Robert Hayman | - | 0 | 10,366 | 15 Aug, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Mar, 2026 | David Moatazedi | Common Stock | D | 13,669 | $4.75 | 604,700 | D | S |
| 20 Mar, 2026 | Rui Avelar | Common Stock | D | 3,119 | $4.75 | 427,423 | D | S |
| 16 Mar, 2026 | Rui Avelar | Common Stock | A | 8,804 | $0.00 | 460,538 | D | M |
| 16 Mar, 2026 | David Moatazedi | Common Stock | A | 67,489 | $0.00 | 735,089 | D | M |
| 17 Mar, 2026 | David Moatazedi | Common Stock | D | 116,720 | $4.89 | 618,369 | D | S |
| 17 Mar, 2026 | Rui Avelar | Common Stock | D | 29,996 | $4.89 | 430,542 | D | S |
| 16 Mar, 2026 | Rui Avelar | Performance Restricted Stock Units | D | 8,804 | $0.00 | 8,802 | D | M |
| 16 Mar, 2026 | David Moatazedi | Performance Restricted Stock Units | D | 67,489 | $0.00 | 67,488 | D | M |
| 17 Feb, 2026 | David Moatazedi | Common Stock | A | 313,212 | $0.00 | 667,600 | D | A |
| 17 Feb, 2026 | Vikram Malik | Common Stock | A | 45,559 | $0.00 | 321,109 | D | A |
| 17 Feb, 2026 | Brady Stewart | Common Stock | A | 45,559 | $0.00 | 134,188 | D | A |
| 17 Feb, 2026 | Karah Herdman Parschauer | Common Stock | A | 45,559 | $0.00 | 77,742 | D | A |
| 17 Feb, 2026 | Rui Avelar | Common Stock | A | 94,913 | $0.00 | 451,734 | D | A |
| 17 Feb, 2026 | Tatjana Mitchell | Common Stock | A | 121,489 | $0.00 | 226,092 | D | A |
| 17 Feb, 2026 | Albert G Iii White | Common Stock | A | 45,559 | $0.00 | 95,937 | D | A |
| 17 Feb, 2026 | David N Gill | Common Stock | A | 45,559 | $0.00 | 86,887 | D | A |
| 17 Feb, 2026 | David Moatazedi | Performance Restricted Stock Units | A | 626,424 | $0.00 | 626,424 | D | A |
| 17 Feb, 2026 | Tatjana Mitchell | Performance Restricted Stock Units | A | 121,489 | $0.00 | 121,489 | D | A |
| 17 Feb, 2026 | Rui Avelar | Performance Restricted Stock Units | A | 94,913 | $0.00 | 94,913 | D | A |
| 17 Feb, 2026 | Rui Avelar | Stock Option (Right to Buy) | A | 138,649 | $0.00 | 138,649 | D | A |